Sand Grove Capital Management’s Avidity Biosciences RNAM Stock Holding History

Sand Grove Capital Management’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-331,605	Closed	-$23.9M	–	27
2025 Q4	$23.9M	Buy	+331,605	New	+$21.4M	8.11%	6

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $158M AUM

Sand Grove Capital Management's RNAM Position: Q1 2026 in Review

Sand Grove Capital Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 331,605 shares — an estimated $23.9M sold.

Sand Grove Capital Management first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $23.9M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Sand Grove Capital Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Sand Grove Capital Management sold 331,605 Avidity Biosciences shares in Q1 2026, an estimated $23.9M.
Sand Grove Capital Management first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
Sand Grove Capital Management's Avidity Biosciences position peaked at $23.9M in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Sand Grove Capital Management's 13F filing for Q1 2026, filed 15 May 2026.